Literature DB >> 11999366

Ocular manifestation of acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.

Takashi Saito1, Katsuji Shinagawa, Katsuto Takenaka, Keitaro Matsuo, Tadashi Yoshino, Katsuyuki Kiura, Kenji Niiya, Mine Harada.   

Abstract

A 26-year-old woman with acute myeloid leukemia underwent allogeneic peripheral blood stem cell transplantation from an HLA-identical brother. Eighteen days after transplantation, the patient developed grade II acute graft-versus-host disease (GVHD) and was treated with corticosteroids. On day 38, the patient complained of eye pain and lacrimation. A slitlamp examination revealed corneal ulcers and pseudomembranous formation in both eyes. Histologic and immunohistochemical examinations of the pseudomembrane disclosed an infiltrate dominated by T cells. A cytogenetic study of the pseudomembrane by fluorescence in situ hybridization identified a Y chromosome in the infiltrated mononuclear cells. Surveillance cultures from conjunctival swabs were negative. Thus, we diagnosed these ocular manifestations as an ocular involvement of acute GVHD.

Entities:  

Mesh:

Year:  2002        PMID: 11999366     DOI: 10.1007/bf02982052

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  8 in total

1.  Allogeneic peripheral blood stem cell transplantation is coming of age.

Authors:  M Harada
Journal:  Int J Hematol       Date:  1995-07       Impact factor: 2.490

Review 2.  Developments in allogeneic peripheral blood progenitor cell transplantation.

Authors:  N H Russell; A Gratwohl; N Schmitz
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

3.  The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease.

Authors:  D A Jabs; J Wingard; W R Green; E R Farmer; G Vogelsang; R Saral
Journal:  Arch Ophthalmol       Date:  1989-09

4.  Epidermal lesions of the GVHR: evaluation of the role of different MHC and non MHC loci and of the Ly-2+ and L3T4+ T lymphocytes.

Authors:  P F Piguet; A Janin-Mercier; P Vassalli; J H Saurat
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

5.  The eye in bone marrow transplantation. I. Clinical study.

Authors:  L W Hirst; D A Jabs; P J Tutschka; W R Green; G W Santos
Journal:  Arch Ophthalmol       Date:  1983-04

Review 6.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

7.  Ocular manifestations of graft-v-host disease.

Authors:  M K Jack; G M Jack; G E Sale; H M Shulman; K M Sullivan
Journal:  Arch Ophthalmol       Date:  1983-07

8.  Pseudomembranous conjunctivitis following bone marrow transplantation: immunopathological and ultrastructural study of one case.

Authors:  A Janin; T Facon; P Castier; E Mancel; J P Jouet; B Gosselin
Journal:  Hum Pathol       Date:  1996-03       Impact factor: 3.466

  8 in total
  15 in total

1.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

Review 2.  Autoimmunity at the ocular surface: pathogenesis and regulation.

Authors:  M E Stern; C S Schaumburg; R Dana; M Calonge; J Y Niederkorn; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-05-19       Impact factor: 7.313

3.  Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.

Authors:  Kyung-Sun Na; Man Soo Kim
Journal:  J Ocul Pharmacol Ther       Date:  2012-06-25       Impact factor: 2.671

4.  Incidence of ocular manifestations in patients with graft versus host disease after allogeneic stem cell transplant in Riyadh, Saudi Arabia.

Authors:  Tariq Aldebasi; Rabia Bashir; Shiji Gangadharan; Naila A Shaheen; Basil Alhussain; Tariq Almudhaiyan; Bader Alahmari
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

5.  Ophthalmic manifestations of leukemia in a tertiary hospital population of adult nigerian africans.

Authors:  Boniface I Eze; Godswill O Ibegbulam; Sunday Ocheni
Journal:  Middle East Afr J Ophthalmol       Date:  2010-10

Review 6.  The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation.

Authors:  Daniel R Saban
Journal:  Ocul Surf       Date:  2013-12-31       Impact factor: 5.033

7.  Ocular manifestations of graft-versus-host disease: 10 years' experience.

Authors:  Xihui Lin; Harrison Dwight Cavanagh
Journal:  Clin Ophthalmol       Date:  2015-07-03

8.  Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease.

Authors:  Philipp Eberwein; Susanne Issleib; Daniel Böhringer; Hans Mittelviefhaus; Johannes Schwartzkopff; Juergen Finke; Thomas Reinhard
Journal:  Mol Vis       Date:  2013-07-19       Impact factor: 2.367

Review 9.  Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations.

Authors:  Nariman Nassiri; Medi Eslani; Nekoo Panahi; Shiva Mehravaran; Alireza Ziaei; Ali R Djalilian
Journal:  J Ophthalmic Vis Res       Date:  2013-10

Review 10.  Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease.

Authors:  Yoko Ogawa; Yutaka Kawakami; Kazuo Tsubota
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.